Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA] - N0000020028

Pharmacologic Code	N0000020028
Pharmacologic Name	Platelet-derived Growth Factor alpha Receptor Inhibitors
Pharmacologic Uses	kinase inhibitor platelet-derived growth factor receptor alpha (PDGFR-α) blocking antibody
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	73207-101	Qinlock	Non-Proprietary Name: Ripretinib	Tablet	Oral	Deciphera Pharmaceuticals, Llc	ACTIVE